US Patent Issued to QYUNS THERAPEUTICS on Feb. 17 for "Anti-human interleukin 36 receptor monoclonal antibody and methods of use thereof to treat disease" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,870, issued on Feb. 17, was assigned to QYUNS THERAPEUTICS Co. LTD. (Jiangsu, China).

"Anti-human interleukin 36 receptor monoclonal antibody and methods of use thereof to treat disease" was invented by Jiwan Qiu (Jiangsu, China), Wang Li (Jiangsu, China), Yi Zhou (Jiangsu, China), Wei Chen (Jiangsu, China), Yong Kong (Jiangsu, China), Huaiyao Qiao (Jiangsu, China), Yiliang Wu (Jiangsu, China) and Tao Chen (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an anti-human interleukin 36 receptor (IL-36R) monoclonal antibody and a use thereof. The monoclonal antibody comprises three heavy chain complementarity...